The physiological disposition of (2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyloxy) acetic acid in the rat, dog, rhesus monkey, and baboon
Zacchei, A.G.; Wishousky, T.I.; Watson, L.S.
Drug Metabolism and Disposition the Biological Fate of Chemicals 6(3): 313-320
1978
ISSN/ISBN: 0090-9556 PMID: 26553 Document Number: 131354
Document emailed within 1 workday
Related Documents
Fanelli, G.M.; Bohn, D.L.; Scriabine, A.; Beyer, K.H. 1977: Saluretic and uricosuric effects of (6, 7-dichloro-2-methyl=1-oxo-2-phenyl-5-indanyloxy) acetic acid (MK-196) in the chimpanzee Journal of Pharmacology and Experimental Therapeutics 200(2): 402-412McConnell, W.R.; El Dareer, S.M.; Hill, D.L. 1980: Metabolism and disposition of erythro-9-(2-hydroxy-3-nonyl)[14C]adenine in the rhesus monkey Drug Metabolism and Disposition: the Biological Fate of Chemicals 8(1): 5-7
Imam, HME. 2000: Some morphological studies on the spleen and its arterial segmentation in baboon monkey (hamadryas baboon) Assiut Veterinary Medical Journal 438(5): 1-12
Chen, S. 1990: Experimental research on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian animal models in the rhesus monkey and C57 black mouse Zhonghua Yi Xue Za Zhi 70(5): 252-254; 18
Lardy, C.; Rousselot, C.; Chavernac, G.; Depin, J.C.; Guerrier, D. 1994: Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate Arzneimittel-Forschung 44(11): 1196-1202
Adamson, P.C.; Murphy, R.F.; Godwin, K.A.; Ulm, E.H.; Balis, F.M. 1995: Pharmacokinetics of 9-cis-retinoic acid in the rhesus monkey Cancer Research 55(3): 482-485
Weber, H.; Fischer, B.; Rogal, L.; Spatz, W.B.; Illing, R.B. 1989: Macro square wave jerks in a rhesus monkey: physiological and anatomical findings in a case of selective impairment of attentive fixation Journal für Hirnforschung 30(5): 603-611
Linari, G.; Spanò, R. 1973: Substituted anilides of 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic acid Arzneimittel-Forschung 23(1): 89-91
Biniecki, S.; Horoszkiewicz, Z. 1974: Synthesis of indolyl-3-acetic acid (1-phenyl-2-3-dimethyl-5-oxo-4-pyrazolyl) amide of 3-indolylacetic acid and N-methyl-(1-phenyl-2,3-3-indolylacetic acid Acta Poloniae Pharmaceutica 31(2): 151-155
Everett, S.A.; Candeias, L.P.; Denny, W.A.; Wardman, P. 1994: Decarboxylation of the antitumour drugs flavone-8-acetic acid and xanthenone-4-acetic acid by nitrogen dioxide Anti-Cancer Drug Design 9(1): 68-72
Chasseaud, L.F.; Fry, B.J.; Valzelli, G.; Tosolini, G.P. 1974: Metabolic fate of the anti-inflammatory agent alpha-(4-(1-oxo-2-isoindolinyl)-phenyl)-propionic acid (K 4277) in the rhesus monkey Arzneimittel-Forschung 24(10): 1606-1609
Poston, R.S.; Robbins, R.C.; Chan, B.; Simms, P.; Presta, L.; Jardieu, P.; Morris, R.E. 2000: Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients Transplantation 69(10): 2005-2013
Lynn, R.K.; Wong, K.; Garvie-Gould, C.; Kennish, J.M. 1981: Disposition of the flame retardant, tris(1,3-dichloro-2-propyl) phosphate, in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 9(5): 434-441
Kalla, N.R.; Vasudev, M. 1981: Studies on the male antifertility agent-gossypol acetic acid. II. Effect of gossypol acetic acid on the motility and ATPase activity of human spermatozoa Andrologia 13(2): 95-98
Pirie, H.M.; Breeze, R.G.; Selman, I.E.; Wiseman, A. 1976: Indole-acetic acid, 3-methyl indole and type 2 pneumonocyte hyperplasia in a proliferative alveolitis of cattle Veterinary Record 98(13): 259-260
Baruffini, A.; Borgna, P. 1978: 2-amino-3,5-dichloro-benzoic acid and 3-amino-2,5-dichloro-benzoic acid derivatives with phytotoxic action Il Farmaco; Edizione Scientifica 33(4): 281-287
De Arcangelis, A. 1971: On the use in anti-rheumatic therapy of a new non-steroid anti-inflammatory agent: glucosamide of monohydrated (N-p-chloro-benzoyl-2-methyl-5-methoxy)-indol-3-acetic acid La Clinica Terapeutica 59(3): 229-239
Bianco, T.; Centore, R.; Giannetti, P.; Scuri, R. 1992: Compared kinetics of 2-(2,3-dihydro-5-acetoxy-4,6,7-trimethylbenzofuranyl) acetic acid (IRFI 016) and its active metabolite 2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofuranyl) acetic acid (IRFI 005) in plasma and bronchial alveolar liquid in mice Drugs under Experimental and Clinical Research 18(3): 93-97
Nakajima, M.; Adachi, I.; Ueda, M. 1993: Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey Arzneimittel-Forschung 43(12): 1276-1282
Swaisland, A.J.; Pierce, D.M.; Franklin, R.A. 1977: The disposition of a novel pyrimidoindole, ciclazindol, in the rat and patas monkey Drug Metabolism and Disposition: the Biological Fate of Chemicals 5(5): 419-424